Dharam V. Ablashi
- Epidemiology top 0.2%
- Cytomegalovirus and herpesvirus research 93
- Herpesvirus Infections and Treatments 65
- Oncology top 0.5%
- Viral-associated cancers and disorders 82
- Polyomavirus and related diseases 8
- Infectious Diseases top 0.5%
- Parvovirus B19 Infection Studies 25
- Virology top 2%
- Psychiatry and Mental health top 2%
- Fibromyalgia and Chronic Fatigue Syndrome Research 7
-
- T-cell and Retrovirus Studies 11
-
- Virus-based gene therapy research 6
- Co-authors
- S. Zaki SalahuddinFlossie Wong‐StaalSteven F. JosephsRobert C. GalloPhillip D. MarkhamMark H. KaplanPeter BiberfeldRichard L. Gallo
- Journals
- Nature (1 paper)Science (2 papers)Proceedings of the National Academy of Sciences (2 papers)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Dharam V. Ablashi
140 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Epidemiology 4.6k
- Oncology 3.3k
- Infectious Diseases 1.7k
- Virology 384
- Psychiatry and Mental health 589
Countries citing papers authored by Dharam V. Ablashi
This map shows the geographic impact of Dharam V. Ablashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dharam V. Ablashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dharam V. Ablashi more than expected).
Fields of papers citing papers by Dharam V. Ablashi
This network shows the impact of papers produced by Dharam V. Ablashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dharam V. Ablashi. The network helps show where Dharam V. Ablashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Dharam V. Ablashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2020 | 3 | |
| 3 | 2018 | 18 | |
| 4 | 2016 | 16 | |
| 5 | The Antimicrobial Compound, K21, Inhibits Replication of Enveloped and Non-Enveloped DNA and RNA Viruses | 2015 | 1 |
| 6 | 2013 | 50 | |
| 7 | 2010 | 9 | |
| 8 | 2010 | 71 | |
| 9 | 2009 | 62 | |
| 10 | 2003 | 110 | |
| 11 | 2000 | 22 | |
| 12 | 1999 | 26 | |
| 13 | 1998 | 22 | |
| 14 | 1996 | 9 | |
| 15 | 1994 | 30 | |
| 16 | 1993 | 1 | |
| 17 | 1993 | 9 | |
| 18 | 1991 | 7 | |
| 19 | 1989 | 245 | |
| 20 | 1988 | 104 |
About Dharam V. Ablashi
Dharam V. Ablashi is a scholar working on Oncology, Epidemiology and Infectious Diseases, having authored 142 papers that have together received 6.4k indexed citations. Recurring topics across this work include Cytomegalovirus and herpesvirus research (93 papers), Viral-associated cancers and disorders (82 papers), Herpesvirus Infections and Treatments (65 papers), Parvovirus B19 Infection Studies (25 papers), T-cell and Retrovirus Studies (11 papers), Polyomavirus and related diseases (8 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (7 papers) and Virus-based gene therapy research (6 papers). The work is most often cited by research in Epidemiology (4.6k citations), Oncology (3.3k citations) and Infectious Diseases (1.7k citations). Dharam V. Ablashi has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include S. Zaki Salahuddin, Flossie Wong‐Staal, Steven F. Josephs, Robert C. Gallo, Phillip D. Markham, Mark H. Kaplan, Peter Biberfeld, Richard L. Gallo, Louise G. Chatlynne and James E. Whitman. Their work appears in journals such as Nature, Science and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.